期刊文献+

中药治疗慢性盆腔炎不同给药途径疗效观察 被引量:6

Chronic Pelvic Inflammatory:Efficacy of Different Routes of Administration of Traditional Chinese Medicine
原文传递
导出
摘要 目的:探讨中药治疗慢性盆腔炎不同给药途径的临床疗效及远期效果。方法:通过随机的方法将156例慢性盆腔炎患者分成3组,分别给予中药下腹部热敷、康妇消炎栓直肠给药和妇平胶囊口服的方法,并随访观察患者的临床疗效及远期效果。结果:中药下腹部热敷给药组临床有效率94.32%、康妇消炎栓直肠给药组有效率73.08%、妇平胶囊口服有效率76.92%;中药热敷给药组临床有效率与其他两组比较疗效显著(P<0.05)。从远期效果看中药热敷组复发率为4.08%、直肠给药组复发率为5.26%、口服给药组复发率为17.5%;中药热敷和直肠给药组远期效果相对于口服给药组有显著差异(P<0.05),优于口服给药组。结论:中药热敷治疗慢性盆腔炎临床疗效显著,且耐受性和临床远期效果佳,值得临床推广使用。 Objective:To explore the clinical efficacy of different routes of administration of traditional Chinese medicine for chronic pelvic inflammatory disease and long-term results.Methods:A total of 156 cases of chronic pelvic inflammatory disease were randomly divided into three groups, hot Chinese traditional herbal medicine compress group under the administration of the abdomen, suppository of Kangfuyan rectal administration group and capsule of Fuping orally group, and observation of clinical efficacy and long-term results.Results:Hot Chinese traditional medicine group clinical effective is 94.32%, suppository of Kangfuyan rectal administration group is 73.08%, capsule of Fuping orally group clinical effective is 76.92%.Hot Chinese traditional medicine group clinical efficiency and efficacy of the other two groups were significantly (P0.05).Herbal Compress from the long-term results to see the recurrence rate was 4.08% group.Rectal recurrence rate was 5.26% group.Oral treatment group the recurrence rate was 17.5%.Herbal Compress and group long-term effects of rectal administration of service delivery relative to the oral group were significantly different (P0.05).Conclusion:Herbal Compress for chronic pelvic inflammatory disease has a significant effect and long-term tolerability, worthy to be clinically used.
出处 《现代生物医学进展》 CAS 2010年第11期2097-2099,共3页 Progress in Modern Biomedicine
关键词 慢性盆腔炎 热敷 直肠 口服 pelvic inflammatory hot compress rectum oral medicine
  • 相关文献

参考文献5

二级参考文献29

共引文献47

同被引文献46

  • 1朱兰,孙智晶.慢性盆腔疼痛的分类、发病机制及非妇科病因[J].实用妇产科杂志,2007,23(4):200-202. 被引量:36
  • 2CDC. Sexually transmitted diseases treatment guideline 2006 [J]. MMWR, 2006, 55(RR-11 ): 1-94. 被引量:1
  • 3Julius S, E. Russell A. Chlamydial Infections. Bacterial Infections of Humans, 2009, 221-247. 被引量:1
  • 4Pippa Oakeshott, Sally Kerry, Adamma Aghaizu, et al. Randomized controlled trial of screening for Chlamydia trachoma is to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial [J]. BMJ, 2010, 340:c 1642. 被引量:1
  • 5Bohm, Michele K, Newman, Loft, et al. Pelvic inflammatory disease among privately insured women, United States, 2001-2005 [J]. Sexually Transmitted Diseases, 2010, 37(3): 131-136. 被引量:1
  • 6V L Short, P A Totten, R B Ness, et al. The demographic, sexual health and behavioural correlates of Mycoplasma genitalium infection among women with clinically suspected pelvic inflammatory disease [J]. Sex Transm Infect, 2010, 86:29-31. 被引量:1
  • 7Richard L Sweet. Treatment strategies for pelvic inflammatory disease [J]. Informa healthcare, 2009, 10(5), 823-837. 被引量:1
  • 8C Bjartling, S Osser, K Person. The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy [J]. BJOG, 2010, 117(3):361-364. 被引量:1
  • 9Femke Mola, Norah M. van Melloa, Ben W. Mola, et al. Ectopic pregnancy and pelvic inflammatory disease: a renewed epidemic? [J]. The European Journal of Obstetrics & Gynecology and Reproductive Biology, 2010, 151(2):163-167. 被引量:1
  • 10Shun-An Lee, Po-Hui Wang, Hui-Ling Chiou, et al. Markedly elevated plasma myeioperoxidase protein in patients with pelvic inflammatory disease who have an allele myeloperoxidase gene polymorphism [J]. Fertility and Sterility, 2010, 93(4): 1260-1266. 被引量:1

引证文献6

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部